Protective effect of lipopolysaccharide preconditioning in hepatic ischaemia reperfusion injury

HPB

Volumn 12, Issue 8, 2010, Pages 538-545

  Sano, Takanori ^a,b   Izuishi, Kunihiko ^a,b   Hossain, Mohammad A ^b   Kakinoki, Keitaro ^b   Okano, Keiichi ^b   Masaki, Tsutomu ^b   Suzuki, Yasuyuki ^b  

^a Takamatsu Red Cross Hospital   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

ischaemia reperfusion; lipopolysaccharide; liver; preconditioning; SOCS 1

Indexed keywords

ALANINE AMINOTRANSFERASE; AUTACOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK1 PROTEIN, MOUSE; LIPOPOLYSACCHARIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOCS1 PROTEIN, MOUSE; SUPPRESSOR OF CYTOKINE SIGNALING; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; C3H MOUSE; DISEASE MODEL; DRUG EFFECT; DRUG POTENTIATION; GENETICS; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER; MALE; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PHOSPHORYLATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TIME; VASCULARIZATION; WESTERN BLOTTING;

ALANINE TRANSAMINASE; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, KNOCKOUT; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TIME FACTORS; TOLL-LIKE RECEPTOR 4;

MLCS; MLOWN;

EID: 79952995008     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00211.x     Document Type: Article

References (32)

1. Takeda, K., Akira, S., TLR signalling pathways. Semin Immunol 16 (2004), 3–9.
2. Kawai, T., Akira, S., Signalling to NF-kappaB by toll-like receptors. Trends Mol Med 13 (2007), 460–469.
3. Biswas, S.K., Lopez-Collazo, E., Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 30 (2009), 475–487.
4. Ha, T., Hua, F., Liu, X., Ma, J., McMullen, J.R., Shioi, T., Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism. Cardiovasc Res 78 (2008), 546–553.
5. Rosenzweig, H.L., Lessov, N.S., Henshall, D.C., Minami, M., Simon, R.P., Stenzel-Poore, M.P., Endotoxin preconditioning prevents cellular inflammatory response during ischaemic neuroprotection in mice. Stroke 35 (2004), 2576–2581.
6. Heemann, U., Szabo, A., Hamar, P., Müller, V., Witzke, O., Lutz, J., Lipopolysaccharide pretreatment protects from renal ischaemia/reperfusion injury: possible connection to an interleukin-6-dependent pathway. Am J Pathol 156 (2000), 287–293.
7. Stein, A.B., Tang, X.L., Guo, Y., Xuan, Y.T., Dawn, B., Bolli, R., Delayed adaptation of the heart to stress: late preconditioning. Stroke 35 (2004), 2676–2679.
8. Bolli, R., The late phase of preconditioning. Circ Res 87 (2000), 972–983.
9. Carini, R., Albano, E., Recent insights on the mechanisms of liver preconditioning. Gastroenterology 125 (2003), 1480–1491.
10. Izuishi, K., Tsung, A., Hossain, M.A., Fujiwara, M., Wakabayashi, H., Masaki, T., Ischaemic preconditioning of the murine liver protects through the Akt kinase pathway. Hepatology 44 (2006), 573–580.
11. Harada, N., Hatano, E., Koizumi, N., Nitta, T., Yoshida, M., Yamamoto, N., Akt activation protects rat liver from ischaemia/reperfusion injury. J Surg Res 121 (2004), 159–170.
12. Izuishi, K., Tsung, A., Jeyabalan, G., Critchlow, N.D., Li, J., Tracey, K.J., Cutting edge: high-mobility group box 1 preconditioning protects against liver ischaemia-reperfusion injury. J Immunol 176 (2006), 7154–7158.
13. Suzuki, S., Toledo-Pereyra, L.H., Rodriguez, F.J., Cejalvo, D., Neutrophil infiltration as an important factor in liver ischaemia and reperfusion injury: modulating effects of FK506 and cyclosporine. Transplantation, 55, 1993, 1265.
14. Toledo-Pereyra, L.H., Simmons, R.L., Najarian, J.S., Protection of the ischaemic liver by donor pretreatment before transplantation. Am J Surg 129 (1975), 513–517.
15. Lentsch, A.B., Kato, A., Yoshidome, H., McMasters, K.M., Edwards, M.J., Inflammatory mechanisms and therapeutic strategies for warm hepatic ischaemia/reperfusion injury. Hepatology 32 (2000), 169–173.
16. Teoh, N.C., Farrell, G.C., Hepatic ischaemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 18 (2003), 891–902.
17. Jaeschke, H., Molecular mechanisms of hepatic ischaemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 284 (2003), 15–26.
18. Zwacka, R.M., Zhang, Y., Zhou, W., Halldorson, J., Engelhardt, J.F., Ischaemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation. Hepatology 28 (1998), 1022–1030.
19. Yoshidome, H., Kato, A., Edwards, M.J., Lentsch, A.B., Interleukin-10 suppresses hepatic ischaemia/reperfusion injury in mice: implications of a central role for nuclear factor kappaB. Hepatology 30 (1999), 203–208.
20. Funaki, H., Shimizu, K., Harada, S., Tsuyama, H., Fushida, S., Tani, T., Essential role for nuclear factor kappaB in ischaemic preconditioning for ischaemia-reperfusion injury of the mouse liver. Transplantation 27 (2002), 551–556.
21. Teoh, N., Field, J., Sutton, J., Farrell, G., Dual role of tumour necrosis factor-alpha in hepatic ischaemia-reperfusion injury: studies in tumour necrosis factor-alpha gene knockout mice. Hepatology 39 (2004), 412–421.
22. Suetsugu, H., Iimuro, Y., Uehara, T., Nishio, T., Harada, N., Hatano, E., Nuclear factor κB inactivation in the rat liver ameliorates short-term total warm ischaemia/reperfusion injury. Gut 54 (2005), 835–842.
23. Lee, C.H., Kim, S.H., Lee, S.M., Effect of pyrrolidine dithiocarbamate on hepatic vascular stress gene expression during ischaemia and reperfusion. Eur J Pharmacol 595 (2008), 100–107.
24. Williams, D.L., Ozment-Skelton, T., Li, C., Modulation of the phosphoinositide 3-kinase signalling pathway alters host response to sepsis, inflammation, and ischaemia/reperfusion injury. Shock 25 (2006), 432–439.
25. Fruman, D.A., Cantley, L.C., Phosphoinositide 3-kinase in immunological systems. Semin Immunol 14 (2002), 7–18.
26. Kawai, T., Akira, S., TLR signalling. Semin Immunol 19 (2007), 24–32.
27. Zhai, Y., Shen, X.D., O'Connell, R., Gao, F., Lassman, C., Busuttil, R.W., Cutting edge: TLR4 activation mediates liver ischaemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 173 (2004), 7115–7119.
28. Tsung, A., Hoffman, R.A., Izuishi, K., Critchlow, N.D., Nakao, A., Chan, M.H., Hepatic ischaemia/reperfusion injury involves functional TLR4 signalling in non-parenchymal cells. J Immunol 175 (2005), 7661–7668.
29. Zhai, Y., Qiao, B., Shen, X.D., Gao, F., Busuttil, R.W., Cheng, G., Evidence for the pivotal role of endogenous toll-like receptor 4 ligands in liver ischaemia and reperfusion injury. Transplantation 85 (2008), 1016–1022.
30. Selzner, N., Rudiger, H., Graf, R., Clavien, P.A., Protective strategies against ischaemic injury of the liver. Gastroenterology 125 (2003), 917–936.
31. Liu, Z.J., Liu, X.L., Zhao, J., Shi, Y.J., Yan, L.N., Chen, X.F., The effects of SOCS-1 on liver endotoxin tolerance development induced by a low dose of lipopolysaccharide are related to dampen NF-kappaB-mediated pathway. Dig Liver Dis 40 (2008), 568–577.
32. Liu, Z.J., Yan, L.N., Li, X.H., Xu, F.L., Chen, X.F., You, H.B., Upregulation of IRAK-M is essential for endotoxin tolerance induced by a low dose of lipopolysaccharide in Kupffer cells. J Surg Res 150 (2008), 34–39.